Company / Net Debt per Share
UTAH MEDICAL PRODUCTS INC Net Debt per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$22.86
FY2024
5-year range
-$25.60 / -$14.16
FY2020-FY2024
Trend
+10.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Debt per Share returned to growth in FY2024 after 3 years of decline, reaching $-22.86.
Based on SEC 10-K filings.
-22.86 in FY2024.
Improved from $-16.68 to $-22.86 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, net debt per share increased 10.7% year-over-year.
- Peak net debt per share was recorded in FY2020.
- Lowest net debt per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$22.86 | +10.7% |
| FY2023 | -$25.60 | -53.4% |
| FY2022 | -$16.68 | -17.8% |
| FY2021 | -$14.16 | -3.1% |
| FY2020 | -$13.73 | +99.9% |
| FY2019 | -$10719.09 | -51.7% |
| FY2018 | -$7066.92 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026